Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain

European Neuropsychopharmacology

Volumn 20, Issue 12, 2010, Pages 895-906

  Higuera Matas, Alejandro ^a   Botreau, Fanny ^a   Del Olmo, Nuria ^c   Miguéns, Miguel ^a   Olías, Óscar ^a   Montoya, Gonzalo L ^a   García Lecumberri, Carmen ^a   Ambrosio, Emilio ^a,b  

^a UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Cannabinoids; Cocaine self administration; Dopamine receptors; Dopamine transporter; Gateway hypothesis

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ADOLESCENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG SELF ADMINISTRATION; EXPOSURE; FEMALE; GENE EXPRESSION; GROUPS BY AGE; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; SUBSTANTIA NIGRA; UPREGULATION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CANNABINOIDS; CORPUS STRIATUM; CYCLOHEXANOLS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SEX FACTORS;

EID: 77958172484     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.017     Document Type: Article

References (68)

1. Anderson S.M., Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 2005, 106:389-403.
2. Anthony J.C. Death of the 'stepping-stone' hypothesis and the 'gateway' model? Comments on Morral et al. Addiction 2002, 97:1505-1507.
3. Arnold J.C. The role of endocannabinoid transmission in cocaine addiction. Pharmacol. Biochem. Behav. 2005, 81:396-406.
4. Becker J.B., Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008, 29:36-47.
5. Beltramo M., Bernardini N., Bertorelli R., Campanella M., Nicolussi E., Fredduzzi S., Reggiani A. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. 2006, 23:1530-1538.
6. Ben-Shahar O., Moscarello J.M., Ettenberg A. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res. 2006, 1095:148-153.
7. Ben-Shahar O., Keeley P., Cook M., Brake W., Joyce M., Nyffeler M., Heston R., Ettenberg A. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 2007, 1131:220-228.
8. Biscaia M., Fernandez B., Higuera-Matas A., Miguens M., Viveros M.P., Garcia-Lecumberri C., Ambrosio E. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55, 940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology 2008, 54:863-873.
9. Black Y.D., Green-Jordan K., Eichenbaum H.B., Kantak K.M. Hippocampal memory system function and the regulation of cocaine self-administration behavior in rats. Behav. Brain Res. 2004, 151:225-238.
10. Bossong M.G., van Berckel B.N., Boellaard R., Zuurman L., Schuit R.C., Windhorst A.D., van Gerven J.M., Ramsey N.F., Lammertsma A.A., Kahn R.S. Delta9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009, 34(3):759-766.
11. Britton D.R., Curzon P., Mackenzie R.G., Kebabian J.W., Williams J.E., Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 1991, 39:911-915.
12. Chao J., Nestler E.J. Molecular neurobiology of drug addiction. Annu. Rev. Med. 2004, 55:113-132.
13. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., Phillips P.E., Wightman R.M. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 2007, 27:791-795.
14. Craft R.M. Sex differences in behavioral effects of cannabinoids. Life Sci. 2005, 77:2471-2478.
15. del Olmo N., Miguens M., Higuera-Matas A., Torres I., Garcia-Lecumberri C., Solis J.M., Ambrosio E. Enhancement of hippocampal long-term potentiation induced by cocaine self-administration is maintained during the extinction of this behavior. Brain Res. 2006, 1116:120-126.
16. Del Olmo N., Higuera-Matas A., Miguens M., Garcia-Lecumberri C., Ambrosio E. Cocaine self-administration improves performance in a highly demanding water maze task. Psychopharmacology (Berlin) 2007, 195(1):19-25.
17. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5274-5278.
18. Ellgren M., Spano S.M., Hurd Y.L. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 2007, 32:607-615.
19. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 1992, 578:235-243.
20. Fergusson D.M., Boden J.M., Horwood L.J. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006, 101:556-569.
21. Ferrer B., Gorriti M.A., Palomino A., Gornemann I., de Diego Y., Bermudez-Silva F.J., Bilbao A., Fernandez-Espejo E., Moratalla R., Navarro M., Rodriguez de Fonseca F. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies. Eur. J. Pharmacol. 2007, 559:180-183.
22. Frey U., Hartmann S., Matthies H. Domperidone, an inhibitor of the D2-receptor, blocks a late phase of an electrically induced long-term potentiation in the CA1-region in rats. Biomed. Biochim. Acta 1989, 48:473-476.
23. Garcia-Gil L., Ramos J.A., Rubino T., Parolaro D., Fernandez-Ruiz J.J. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol. Teratol. 1998, 20:549-553.
24. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
25. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071:10-23.
26. Gonzalez S., Bisogno T., Wenger T., Manzanares J., Milone A., Berrendero F., Di Marzo V., Ramos J.A., Fernandez-Ruiz J.J. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun. 2000, 270:260-266.
27. Hall W.D., Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 2005, 24:39-48.
28. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., Uhl G.R. Molecular mechanisms underlying the rewarding effects of cocaine. Ann. NY Acad. Sci. 2004, 1025:47-56.
29. Higuera-Matas A., Soto-Montenegro M.L., del Olmo N., Miguens M., Torres I., Vaquero J.J., Sanchez J., Garcia-Lecumberri C., Desco M., Ambrosio E. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology 2008, 33:806-813.
30. Higuera-Matas A., Botreau F., Miguens M., Del Olmo N., Borcel E., Perez-Alvarez L., Garcia-Lecumberri C., Ambrosio E. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol. Biochem. Behav. 2009, 93:482-490.
31. Howell D.C. Statistical methods for psychology 2002, Duxbury Press, Pacific Grove, Calif. 5th ed.
32. Ito R., Dalley J.W., Robbins T.W., Everitt B.J. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 2002, 22:6247-6253.
33. Kalivas P.W., McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berlin) 2003, 168:44-56.
34. Kandel D.B., Yamaguchi K., Klein L.C. Testing the gateway hypothesis. Addiction 2006, 101:470-472. discussion 474-6.
35. Kantak K.M., Goodrich C.M., Uribe V. Influence of sex, estrous cycle, and drug-onset age on cocaine self-administration in rats (Rattus norvegicus). Exp. Clin. Psychopharmacol. 2007, 15:37-47.
36. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino L.J. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 2001, 21:2799-2807.
37. Lynskey M. An alternative model is feasible, but the gateway hypothesis has not been invalidated: comments on Morral et al. Addiction 2002, 97:1505-1507.
38. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006, 29:225-232.
39. Manahan-Vaughan D., Kulla A. Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb. Cortex 2003, 13:123-135.
40. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 2002, 81:292-300.
41. Masserano J.M., Baker I., Natsukari N., Wyatt R.J. Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms. Neurosci. Lett. 1996, 217:73-76.
42. McFarland K., Lapish C.C., Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003, 23:3531-3537.
43. Meador-Woodruff J.H., Little K.Y., Damask S.P., Mansour A., Watson S.J. Effects of cocaine on dopamine receptor gene expression: a study in the postmortem human brain. Biol. Psychiatry 1993, 34:348-355.
44. Miguens M., Crespo J.A., Del Olmo N., Higuera-Matas A., Montoya G.L., Garcia-Lecumberri C., Ambrosio E. Differential cocaine-induced modulation of glutamate and dopamine transporters after contingent and non-contingent administration. Neuropharmacology 2008, 55:771-779.
45. Moore R.J., Vinsant S.L., Nader M.A., Porrino L.J., Friedman D.P. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 1998, 30:88-96.
46. Nader M.A., Daunais J.B., Moore T., Nader S.H., Moore R.J., Smith H.R., Friedman D.P., Porrino L.J. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 2002, 27:35-46.
47. Orio L., Edwards S., George O., Parsons L.H., Koob G.F. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J. Neurosci. 2009, 29:4846-4857.
48. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, Burlington, Ma. 5 ed.
49. Pistis M., Perra S., Pillolla G., Melis M., Muntoni A.L., Gessa G.L. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol. Psychiatry 2004, 56:86-94.
50. Porrino L.J., Daunais J.B., Smith H.R., Nader M.A. The expanding effects of cocaine: studies in a nonhuman primate model of cocaine self-administration. Neurosci. Biobehav. Rev. 2004, 27:813-820.
51. Quinlan M.G., Sharf R., Lee D.Y., Wise R.A., Ranaldi R. Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats. Psychopharmacology (Berlin) 2004, 175:53-59.
52. Rodriguez de Fonseca F., Ramos J.A., Bonnin A., Fernandez-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport 1993, 4:135-138.
53. Rodriguez De Fonseca F., Gorriti M.A., Bilbao A., Escuredo L., Garcia-Segura L.M., Piomelli D., Navarro M. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia. Neurotox. Res. 2001, 3:23-35.
54. Romero E.M., Fernandez B., Sagredo O., Gomez N., Uriguen L., Guaza C., De Miguel R., Ramos J.A., Viveros M.P. Antinociceptive, behavioural and neuroendocrine effects of CP 55, 940 in young rats. Brain Res. Dev. Brain Res. 2002, 136:85-92.
55. Ross R.A., Coutts A.A., McFarlane S.M., Anavi-Goffer S., Irving A.J., Pertwee R.G., MacEwan D.J., Scott R.H. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 2001, 40:221-232.
56. Roth M.E., Cosgrove K.P., Carroll M.E. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci. Biobehav. Rev. 2004, 28:533-546.
57. Rowlett J.K., Platt D.M., Yao W.D., Spealman R.D. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 2007, 321:1135-1143.
58. Rubino T., Realini N., Braida D., Guidi S., Capurro V., Vigano D., Guidali C., Pinter M., Sala M., Bartesaghi R., Parolaro D. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 2009, 19:763-772.
59. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol. 2008, 13:253-263.
60. Stander S., Schmelz M., Metze D., Luger T., Rukwied R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci. 2005, 38:177-188.
61. Thompson A.M., Swant J., Gosnell B.A., Wagner J.J. Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience 2004, 127:177-185.
62. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
63. Volkow N.D., Gatley S.J., Fowler J.S., Logan J., Fischman M., Gifford A.N., Pappas N., King P., Vitkun S., Ding Y.S., Wang G.J. Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse 1996, 24:399-402.
64. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Ding Y.S., Logan J., Dewey S.L., Hitzemann R., Lieberman J. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10388-10392.
65. Vrana S.L., Vrana K.E., Koves T.R., Smith J.E., Dworkin S.I. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem. 1993, 61:2262-2268.
66. Wada K. The concept of "gateway drug". Nihon Arukoru Yakubutsu Igakkai Zasshi 1999, 34:95-106.
67. Wilson J.M., Nobrega J.N., Carroll M.E., Niznik H.B., Shannak K., Lac S.T., Pristupa Z.B., Dixon L.M., Kish S.J. Heterogeneous subregional binding patterns of 3H-WIN 35, 428 and 3H-GBR 12, 935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 1994, 14:2966-2979.
68. Wilson J.M., Levey A.I., Bergeron C., Kalasinsky K., Ang L., Peretti F., Adams V.I., Smialek J., Anderson W.R., Shannak K., Deck J., Niznik H.B., Kish S.J. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann. Neurol. 1996, 40:428-439.